NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
10-K - GeoVax Labs, Inc.
Filed:
2026-04-15
AccNo:
0001437749-26-012377
Size:
5 MB
发布时间04/15 19:57 UTC
首次发现04/15 20:00 UTC
热度107.9
重要度90
情绪+0.03
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 663 字符
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001437749-26-012377
Filing Date: 2026-04-15
Accepted: 2026-04-15 15:57:26
Documents: 71
Period of Report: 2025-12-31
GeoVax Labs, Inc. (Filer) CIK : 0000832489 (see all company filings) EIN. : 870455038 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 10-K | Act: 34 | File No.: 001-39563 | Film No.: 26864057 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 10-K | govx20251231_10k.htm iXBRL | 10-K
2 | EXHIBIT 10.6.4 | ex_943249.htm | EX-10.64
3 | EXHIBIT 10.6.5 | ex_943250.htm | EX-10.65
4 | EXHIBIT 23.1 | ex_943251.htm | EX-23.1